This inventor holds 1 USPTO granted patent. Top assignee: Retinal Solutions LLC. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Kenneth Mitton: Innovator in Gene Therapy
Introduction
Kenneth Mitton is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of diseases. His innovative work has led to the development of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Kenneth Mitton holds a patent titled "Norrin Induced Expression of Genes and Use Thereof to Treat Disease." This patent represents a breakthrough in the application of gene therapy, providing new avenues for treating various medical conditions. He has 1 patent to his name, reflecting his commitment to innovation in this critical area of research.
Career Highlights
Mitton is currently associated with Retinal Solutions LLC, a company focused on developing advanced treatments for retinal diseases. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to the development of effective therapies for patients.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including Michael T Trese and Wendelin Dailey. These partnerships have enhanced his research and have been instrumental in the progress of his projects.
Conclusion
Kenneth Mitton is a dedicated inventor whose work in gene therapy is paving the way for innovative treatments. His contributions to the field are significant, and his ongoing efforts at Retinal Solutions LLC continue to impact the medical community positively.